Eric A. Brown, MD, FACS

Breast Cancer Surgeon

Dr. Eric Brown has been involved in the care of breast patients for over 25 years. He is Board Certified in General Surgery and Certified in Breast Ultrasound. He is a member of Karmanos Cancer Institute. He previously served as Breast Multidisciplinary Team Co-Lead, responsible for leading breast care services for the entire Karmanos Network.

Dr. Brown is an Assistant Professor of Surgery at the Wayne State University School of Medicine and Oakland University William Beaumont School of Medicine. He is actively involved in research, as the Co-Principle Investigator of the Beaumont Cancer Institute NCORP (NCI Clinical Oncology Research Program), and is the principle investigator for Beaumont Hospital, on a number of national clinical trials. He is the Director of Research for Targeted Medical Education. TME is an international network of clinicians, researchers, educators and companies. Its core mission is to improve the quality and access to advanced targeted cancer care, by fostering high-quality & comprehensive educational resources and research; by synthesizing "State-of-the-Art" with "State-of-the-Science." TME's specialty is breast cancer from prevention, diagnosis, treatment, to survivorship. He is Co-Leader (along with Dr. Gold) of Breast Multidisciplinary Tumor Board Michigan Healthcare Professionals. He is also the Principle Investigator of multiple clinical trials in our office (with Dr. Gold): FLEX registry, B4 Trial, iGap, PREDICT Registry

What patients are saying about Dr. Brown

Thank you for the superb care you and your staff provided this Spring. From the initial consult to surgery and post-op, I can't imagine a better experience.
I'm appreciative each day for the excellent surgical outcome and the good fortune of my cancer type.

- C.T.



Education

As an undergraduate, Dr. Brown did research at the University of Michigan Medical School. His research won first prize at the University of Michigan Medical School Medical Student Research Forum in 1983. He went on to present his research at the Midwest Student Medical Research Forum XV held at the University of Wisconsin, in 1984.

In his first year in practice, he was elected Young Surgeon Representative, Michigan Chapter, American College of Surgeons.

  • Undergraduate studies: The University of Michigan, Ann Arbor, Michigan
  • Medical School: The University of Health Sciences/The Chicago Medical School, North Chicago, Illinois
  • Internship: Mt. Carmel Mercy Hospital, Detroit, Michigan
  • Residency: Chief Resident, St. John Hospital and Medical Center, Detroit, Michigan

Publications

  • The Clinical Utility of DCISionRT ® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery. Shah C, Bremer T, Cox C, Whitworth P, Patel R, Patel A, Brown E, Gold L, Rock D, Riley L, Kesslering C, Brown S, Gabordi R, Pellicane J, Rabinovich R, Khan S, Templeton S, Majithia L, Willey SC, Wärnberg F, Gerber NK, Shivers S, Vicini FA. Ann Surg Oncol. 2021 Oct;28(11):5974-5984. doi: 10.1245/s10434-021-09903-1. Epub 2021 Apr 5. Erratum in: Ann Surg Oncol. 2021 May 16;: PMID: 33821346; PMCID: PMC8526470.


  • Legacy genetic testing results for cancer susceptibility: How common are conflicting classifications in a large variant dataset from multiple practices?, Yin K, Liu Y, Lamichhane B, Sandbach JF, Patel G, Compagnoni G, Kanak RH, Rosen B, Ondrula DP, Smith L, Brown E, Gold L, Whitworth P, App C, Euhus D, Semine A, Lyons SD, Lazarte MA, Parmigiani G, Braun D, Hughes KS, Annals of Surgical Oncology, in press. doi: 10.1245/s10434-020-08492-9.


  • Resection of Cavity Shave Margins in Stage 0–III Breast Cancer Patients Undergoing Breast Conserving Surgery A Prospective Multicenter Randomized Controlled Trial, Elisabeth Dupont, MD, Theodore Tsangaris, MD, Carlos Garcia-Cantu, MD, Marissa Howard-McNatt, MD, Akiko Chiba, MD, Adam C. Berger, MD, Edward A. Levine, MD, Jennifer S. Gass, MD, Kristalyn Gallagher, DO, Sharon S. Lum, MD, Ricardo D. Martinez, MD, Alliric I. Willis, MD, Sonali V. Pandya, MD, Eric A. Brown, MD, Andrew Fenton, MD, Amanda Mendiola, MD, Mary Murray, MD, Naveenraj L. Solomon, MD, Maheswari Senthil, MD, David W. Ollila, MD, David Edmonson, MD, Melissa Lazar, MD, Jukes P. Namm, MD, Fangyong Li, MPH, Meghan Butler, BS, Noreen E. McGowan, RN, Maria E. Herrera, RN, Yoana P. Avitan, CCRC, Brian Yoder, DO, Laura L. Walters, MD, PhD, Tara McPartland, MSW,§§ and Anees B. Chagpar, MD, MSc, MPH, MA, MBA, Annals of Surgical Oncology, 2019.Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?Peter D. Beitsch, MD; Pat W. Whitworth, MD; Kevin Hughes, MD; Rakesh Patel, MD; Barry Rosen, MD; Gia Compagnoni, MD; Paul Baron,MD; Rache Simmons,MD; Linda Ann Smith,MD; Ian Grady, MD;Michael Kinney, MD; Cynara Coomer,MD; Karen Barbosa, DO; Dennis R. Holmes, MD; Eric Brown, MD; Linsey Gold, DO; Patricia Clark, MD; Lee Riley, MD, PhD; Samuel Lyons, MD; Antonio Ruiz, MD; Sadia Kahn, DO; Heather MacDonald, MD; Lisa Curcio, MD; Mary Kay Hardwick; Shan Yang, PhD; Ed D. Esplin, MD, PhD; and Robert L. Nussbaum, MD


  • Are Genetic Testing Guidelines still Relevant?,Beitsch PD, Whitworth P, Patel R, Baron P, Rosen B, Grady I, Barbosa K, Compagnoni G, Holmes D, Ruiz A, Smith LA, Simmons R, Kinney M, Coomer C, Brown E , Gold L, Curcio L, Clark P, MacDonald H,  Riley L, Lyons S, Yang S, Esplin E, Oral presentation at American Society of Breast Surgeons, May 2018 (selected as one of top ten scientific submissions for 2018)


  • Variation in Genetic Variants in Breast Cancer Patients Meeting NCCN Criteria vs Those Who Do Not, Preliminary Findings from the Universal Breast Cancer Genetic Testing Registry,Beitsch PD, Whitworth P, Patel R, Baron P, Rosen B, Grady I, Barbosa K, Compagnoni G, Holmes D, Ruiz A, Smith LA, Simmons R, Kinney M, Coomer C, Brown E , Gold L, Curcio L, Clark P, MacDonald H,  Riley L, Lyons S, Yang S, Esplin E, Poster, American Society of Breast Surgeons, April 2018


  • Update of the ASBrS NSM Registry. Breast Cancer Coordinated Care (BC3) Conference, March2, 2018.


  • Universal Genetic Testing for All Breast Cancer Patients – Ready for Prime Time?, Preliminary Findings from the Universal Breast Cancer Genetic Testing Registry,Beitsch PD, Whitworth P, Patel R, Baron P, Rosen B, Grady I, Barbosa K, Compagnoni G, Holmes D, Ruiz A, Smith LA, Simmons R, Kinney M, Coomer C, Brown E , Gold L, Curcio L, Clark P, MacDonald H,  Riley L, Lyons S, Yang S, Esplin E, Miami Breast Cancer Conference, March 2018.


  • Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812); Cancer Prev Res (Phila). 2019 July; 12(7): 481-490.


  • Representation of Minorities and Elderly in Cancer Clinical Trials at a Single Instution-The William Beaumont Hospital Experience; Journal of Cancer Epidemiology and Prevention; Vol. 2, No 1:1; 2017.


  • American Society of Breast Surgeons Nipple Sparing Mastectomy Registry; Preliminary Oncologic Outcome. American Society of Breast Surgeons 17th Annual Meeting, Dallas Texas April 13-17, 2016; Poster – Abstract


  • Post Operative Complication Rates in Prophylactic vs. Therapeutic Nipple Sparing Mastectomies. A Preliminary Analysis of the American Society of Breast Surgeons Nipple Sparing Mastectomy Registry. BC3 Breast Cancer Coordinated Care Conference, Washington DC, March 31-April 2, 2016; Poster AbstractAssociation of Incision Type and Infection Rate in Nipple Sparing Mastectomies. A preliminary Analysis of the American Society of Breast Surgeons Nipple Sparing Mastectomy Registry. American Society of Breast Surgeons 16th Annual Meeting, Orlando, FL, May 2, 2015.


  • Nipple Sparing Mastectomy-Infectious Complication Risk. A preliminary assessment of the American Society of Breast Surgeons Nipple Sparing Mastectomy Registry. San Antonio Breast Cancer Symposium, December 4-8, 2013.


  • Compatibility of breast size, degree of ptosis, type of reconstruction, and incision placement in Nipple Sparing Mastectomies. American Society of Breast Surgeons 14th Annual Meeting, May 1-5, 2013, Chicago, IL.


  • Subareolar tissue specimen assessment in Nipple Sparing Mastectomies. A preliminary analysis of the American Society of Breast Surgeons Nipple Sparing Mastectomy Registry. Society of Surgical Oncology, 66th Annual Cancer Symposium, March 6-9, 2013. National Harbor, Maryland.


  • Incidence rate of nipple areolar complex ischemia after nipple sparing mastectomy. Analysis of the American Society of Breast Surgeons Nipple Sparing Mastectomy Registry. 2012 CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio. December 4-8, 2012.


  • Accelerated Partial Breast Radiation, poster presentation American Society of Breast Surgeons (2009)


  • Use of Breast MRI, poster presentation American Society of Breast Surgeons (2008)


  • Ergotism, presented at The 22nd Annual Symposium on Vascular Surgery (1994) & The Society for Clinical Vascular Surgery Collar Day (1994)


  • Immune Reaction to Hypovolemic Shock, published in The American Surgeon, 1995, presented at The Michigan Chapter, American College of Surgeons (1994), Keyport-Gaylord Trauma Symposium (1994) & The 37th Annual Meeting of the Midwest Surgical Association (1994)


  • Efficacy of Laparoscopic Cholecystectomy, published in The American Surgeon, 1993, present at The 34th Annual Meeting, Midwest Surgical Association (1992)


  • Immediate Implant Reconstruction in Nipple Sparing Mastectomy. An Analysis of the American Society of Breast Surgeons Nipple Sparing Mastectomy Registry. Miami Breast Conference, 32nd Annual Meeting, February 26, 2015.


  • Implementation of an oncology exercise and wellness rehabilitation program to enhance survivorship: the Beaumont Health System experience. JCSO 2014; 12:87-91.


  • Cup Size and Nipple Sparing Mastectomy. ASCO Annual Meeting, May 30-June 3, 2014.


  • Ptosis and Nipple Sparing Mastectomy. A Preliminary Assessment of the American Society of Breast Surgeons Nipple Sparing Mastecotmy Registry. American Society of Breast Surgeons, 15th Annual Meeting, April 30-May 4, 2014, Las Vegas, NV.


  • Four-year results using balloon-based brachytherapy to deliver accelerated partial break irradiation with a 2-day dose fractionation schedule. Brachytherapy; 11(2012): 97-104.


  • Tracheomalacia, published University of Toronto Medical Journal (1990)


  • Relating Epigastric Pain and Intramural Acidosis in Patients with Intestinal Ischemia, presented Midwest Student Medical Research Forum XV, University of Wisconsin, 1984, University of Michigan Medical School Medical Student Research Forum, 1983.

Honors and Awards

Voted ‘Top Doc’ Metro Detroit (2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2021, 2022)
Oakland University William Beaumont Nominee : 2020 Clinical Sciences Educator of the Year Award

Newsweek Magazine: Top Cancer Doctor 2015 (Breast Surgery)

In The News

Dr. Brown and Gold are involved in clinical trials seeking to address the denial of access to genetic testing in breast cancer patients. Universal genetic testing should be a breast cancer patients right as it affects treatment decisions and could have repercussions on family members.



Share by: